These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 646520
21. Effects of calcium antagonists on coronary spasm and pulmonary artery contraction in comparison to their antagonistic action against K-strophanthin in isolated guinea pig atria. Lindner E, Ruppert D. Pharmacology; 1982; 24(5):294-302. PubMed ID: 7100259 [Abstract] [Full Text] [Related]
22. [Selective inhibition of myocardial contractility by competitive divalent Ca++ antagonists (iproveratril, D 600, prenylamine)]. Fleckenstein A, Tritthart H, Fleckenstein B, Herbst A, Grün G. Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):227-8. PubMed ID: 4242380 [No Abstract] [Full Text] [Related]
23. Interaction between adenosine and antiarrhythmic agents in atrial myocardium of guinea-pig. Mészáros J, Kelemen K, Kecskeméti V, Kovács G. Arch Int Pharmacodyn Ther; 1986 Mar; 280(1):84-96. PubMed ID: 3718084 [Abstract] [Full Text] [Related]
24. A comparison of the cardiac and vasodilatory effects of some calcium entry blockers in perfused isolated guinea-pig hearts. Boddeke HW, Wilffert B, Heynis JB, van de Haar Keuken V, Jonkman FA, van Zwieten PA. Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):175-85. PubMed ID: 3675080 [Abstract] [Full Text] [Related]
25. [Parallel influence of isometric tension development and O2 consumption of isolated papillary muscles under the influence of Ca ions, adrenaline, isoproteranol and organic Ca antagonists (iproveratril, D 600, prenylamine)]. Byon KY, Fleckenstein A. Pflugers Arch; 1969 Aug; 312(1):R8-9. PubMed ID: 5390309 [No Abstract] [Full Text] [Related]
26. Hoe 263, a new substance with calcium channel antagonistic activity. Lindner E, Ruppert D, Kaiser J. Pharmacology; 1984 Aug; 29(3):165-72. PubMed ID: 6483963 [Abstract] [Full Text] [Related]
27. Cardiovascular effects of the new dihydropyridine derivative elgodipine. Tamargo J, López-Sendón J, Delpón E, González-Morales M, de Miguel E. Arzneimittelforschung; 1991 Sep; 41(9):895-900. PubMed ID: 1796916 [Abstract] [Full Text] [Related]
28. Myocardial fiber necrosis due to intracellular Ca overload-a new principle in cardiac pathophysiology. Fleckenstein A, Janke J, Döring HJ, Leder O. Recent Adv Stud Cardiac Struct Metab; 1974 Sep; 4():563-80. PubMed ID: 4468468 [No Abstract] [Full Text] [Related]
29. Effect of Chinoin-103, a new antiarrhythmic drug, on the transmembrane potentials, ionic currents and contractile force in heart muscle. Mészáros J, Kelemen K, Markó R, Kecskeméti V, Korbonits D, Kovács G, Szegi J. Arch Int Pharmacodyn Ther; 1983 Apr; 262(2):250-67. PubMed ID: 6135400 [Abstract] [Full Text] [Related]
30. Inotropic and electrophysiological effects of AB--2, a new antiarrhythmic agent, on isolated cardiac preparations. Beresewicz A, Pytkowski B, Sedek G, Zdanowski K. Pol J Pharmacol Pharm; 1983 Apr; 35(3):223-32. PubMed ID: 6651921 [Abstract] [Full Text] [Related]
31. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644. Schramm M, Towart R, Kazda S, Thomas G, Franckowiak G. Adv Myocardiol; 1985 Apr; 6():59-70. PubMed ID: 2581301 [Abstract] [Full Text] [Related]
32. Differences in the cardiac actions of the calcium antagonists verapamil and nifedipine. Raschack M. Arzneimittelforschung; 1976 Apr; 26(7):1330-3. PubMed ID: 1036918 [Abstract] [Full Text] [Related]
33. Action potential, membrane currents and force of contraction in mammalian heart muscle fibers treated with quinidine. Nawrath H. J Pharmacol Exp Ther; 1981 Jan; 216(1):176-82. PubMed ID: 7452504 [Abstract] [Full Text] [Related]
34. Positive inotropic and chronotropic effects of toborinone and its electrophysiological properties in the isolated hearts of rabbits and guinea-pigs. Takase H, Orito K, Mori T, Fujiki H, Sekiguchi K, Tominaga M, Iijima T. Arzneimittelforschung; 1996 Jun; 46(6):579-86. PubMed ID: 8767347 [Abstract] [Full Text] [Related]
35. Calcium blocking properties of piprofurol. Pourrias B, Huerta F, Santamaria R, Bowe C. Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):223-39. PubMed ID: 4026458 [Abstract] [Full Text] [Related]
36. Vascular and cardiac effects of a new dihydropyridine derivative, YC-170: a comparison with Bay K 8644. Hattori Y, Nakaya H, Tohse N, Kanno M. J Pharmacol Exp Ther; 1986 Aug; 238(2):670-8. PubMed ID: 2426442 [Abstract] [Full Text] [Related]
37. Effect of phentolamine, alprenolol and prenylamine on maximum rate of rise of action potential in guinea-pig papillary muscles. Sada H. Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct; 304(3):191-201. PubMed ID: 714177 [Abstract] [Full Text] [Related]
38. Cardiac action of KB-944, a new calcium antagonist. Morita T, Ito K, Nose T. Arzneimittelforschung; 1982 Oct; 32(9):1053-5. PubMed ID: 6890825 [Abstract] [Full Text] [Related]
39. [On the method of action of new types of coronary dilatators with simultaneous oxygen-saving myocardial effects, prenylamine and iproveratril. 2]. Fleckenstein A, Kammermeier H, Döring HJ, Freund HJ. Z Kreislaufforsch; 1967 Aug; 56(8):839-58. PubMed ID: 5592708 [No Abstract] [Full Text] [Related]
40. [Influence of hexobendine, prenylamine and verapamil on the contractile response of isolated rabbit left atria and aortae to calcium (author's transl)]. Shibata K, Hayashi S, Toda N. Nihon Yakurigaku Zasshi; 1977 Nov; 73(8):931-8. PubMed ID: 611068 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]